Hepatic Metabolic Disorders

1

Review clinical trials related to Hepatic Metabolic Disorders. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients

From a scientific point of view and for publication purposes, it therefore seems important to study the metabolism of iron and in particular to define its conditions of absorption, metabolism, elimination and storage in the body at course of advanced renal failure. The study will follow the evolution of hormones regulating iron metabolism and put into perspective their links with phosphocalcic and hepatic metabolisms as well as inflammation in hemodialysis patients. The main objective of this program is to study the evolution of hepcidin and erythroferrone levels in hemodialysis patients. These two biomarkers regulating iron metabolism are not performed routinely in dialysis centers and are not listed in the nomenclature.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Ramsay Générale de SantéUpdated: Oct 19, 2022Locations: 1
Eligibility criteria

Adult dialysis patient [+2]

Medically unstable or frail patient [+5]